Report error Found 611 Enz. Inhib. hit(s) with Target = 'Interferon-induced, double-stranded RNA-activated protein kinase'
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info
TargetInterferon-induced, double-stranded RNA-activated protein kinase [252-551]/Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116](Human)
HiberCell, Inc.
US Patent
HiberCell, Inc.
US Patent
Ligand Info

















































